Table of Contents

Rapid-acting insulins like Fiasp and Novolog are an important part of many people’s diabetes management plans. Both are designed to work quickly, helping patients manage post-meal blood sugar spikes. They both contain insulin aspart as the base formula. However, many prefer Fiasp because of its additional ingredients that result in ultra-fast glucose-lowering action. Meanwhile, those with fixed mealtime schedules may choose NovoLog since it works well with most diabetes plans. That leads us to the question: what’s the difference between the two? Explore the pros and cons of these insulin types in this Fiasp vs. Novolog guide.

Key Takeaways

  • Fiasp and NovoLog (also called NovoRapid) are both rapid-acting insulins approved for managing diabetes in children and adults.
  • Fiasp is prescribed for pediatric patients at least 2 years old and adults with Type 1 or Type 2 diabetes.
  • NovoLog is recommended for children 2 years and older with Type 1 diabetes and adults with either Type 1 or Type 2 diabetes.
  • Fiasp and NovoLog have a similar base molecule —  insulin aspart — but Fiasp has added niacinamide and L-arginine in its formula, promoting faster insulin absorption.
  • Both Fiasp and NovoLog are manufactured by Novo Nordisk — their price difference isn’t significant.

NovoLog vs. Fiasp: Active Ingredient

Both NovoLog and Fiasp have the same active ingredient — insulin aspart. It’s a rapid-acting insulin designed to quickly lower glucose levels after meals. It mimics the body’s natural insulin, facilitating glucose absorption into cells to regulate blood glucose effectively. 

The FDA approved Fiasp and NovoLog in 2020 to enhance glycemic control in people with diabetes. They can be administered either subcutaneously or through IV infusion. 

Additional Ingredients

Insulin Aspart

Fiasp is a formulation of insulin aspart with niacinamide and L-arginine, setting it apart from NovoLog, which only contains insulin aspart.

Niacinamide significantly enhances insulin absorption, allowing Fiasp to start working within minutes after injection. This rapid absorption improves effectiveness by quickly moderating post-meal blood sugar spikes. 

Fiasp also contains L-arginine, which serves as a stabilizing agent. It opens or dilates the blood vessels, allowing the niacinamide to more effectively enhance blood flow and permeability at the injection site, leading to quicker absorption into the bloodstream.

NovoLog doesn’t contain any other special additives, relying solely on insulin aspart. 

Understanding how these extra ingredients impact insulin performance can help you and your doctor select the most suitable insulin for diabetes management.

NovoLog vs. Fiasp: How Quickly Do They Work?

In a study involving adults with Type 1 diabetes, researchers found that Fiasp appeared in circulation about 2.5 minutes after injection. Meanwhile, NovoLog typically begins acting within 10 to 15 minutes after injection. 

The faster onset of Fiasp makes it ideal for regulating blood sugar spikes, even if you eat or snack unexpectedly. Meanwhile, you’ll need pre-meal planning when using NovoLog since its effects take longer. 

So, between Fiasp and NovoLog, which is better for lowering post-meal blood sugar fluctuations? It depends on your needs. Fiasp is faster, but both are effective at managing diabetes. Fiasp may be a better fit if your meal schedule varies frequently.

Which Gets Absorbed Faster? 

Thanks to its niacinamide and L-arginine additives, Fiasp is absorbed more quickly than NovoLog. In fact, Fiasp appears in the bloodstream two times faster than NovoLog. 

This faster glucose-lowering action makes Fiasp especially helpful for patients prone to post-meal blood sugar spikes. Faster absorption helps minimize the risk of high blood sugar and all associated health complications. 

Fiasp vs. NovoLog Dosing Guide

Here’s a table comparing their dosage forms, strengths, and how they’re administered. 

Dosing Information Fiasp NovoLog
Strengths and Forms 100 units/mL (U-100) available as:
  • 10 mL multiple-dose vial 
  • 3 mL single-patient-use FIASP FlexTouch® pen 
  • 3 mL single-patient-use PenFill® cartridges for use in a PenFill cartridge device
  • 1.6 mL single-patient-use PumpCart® cartridges for use in a compatible pump
100 units/mL (U-100) of insulin aspart available as:
  • 10 mL multiple-dose vial 
  • 3 mL single-patient-use PenFill® prefilled cartridge for the 3 mL PenFill cartridge device
  • 3 mL single-patient-use FlexPen® prefilled pen 
  • 3 mL single-patient-use FlexTouch® prefilled pen
Administration At the start of a meal or within 20 minutes after starting a meal Inject within 5-10 minutes before a meal
Injection Sites Abdomen, upper arm, or thigh Abdominal area, thigh, buttocks, or upper arm

There’s no standard dose for Fiasp or NovoLog. Both rapid-acting insulins are dosed based on individual needs and individualized by your doctor. 

Factors that determine your insulin dose often include your body weight, carbohydrate consumption, and insulin sensitivity. Healthcare providers also factor in your blood sugar trends, other coexisting conditions, and activity levels. Being physically active can lower your insulin needs. 

Regarding administration, Fiasp is injected subcutaneously at the start of the meal or within 20 minutes after starting your meal. Meanwhile, NovoLog is injected under the skin 5-10 minutes before a meal. Both are available in FlexTouch pens, pre-filled pens, and vials, making them convenient and user-friendly. 

If you’re switching medications, the NovoLog to Fiasp conversion on patients already on mealtime insulin is typically 1:1, meaning one unit of Fiasp replaces one unit of NovoLog. If you’re on NovoLog, you can swap to Fiasp using the same unit-to-unit dose, unless your doctor tells you otherwise. 

Duration of Action: How Long Do Effects Last?

Fiasp vial and pen

Features Fiasp NovoLog
Peak 91 minutes  1-3 hours
Duration of Action Up to 5 hours 3-5 hours

In clinical trials, a dose of 0.1 unit/kg of weight of Fiasp peaked about 91 minutes after injection. The duration lasted 5 hours before returning to baseline. 

Meanwhile, NovoLog’s duration of action lasted 3-5 hours, while its blood-lowering effect peaked between 1 and 3 hours after injection.

This information matters for meal planning. If you consume your food quickly and want insulin with a faster blood sugar-lowering effect, Fiasp may be a better choice over NovoLog.

If your blood sugar dips too soon after eating, NovoLog’s slower onset gives your body more time to digest food before the effects of insulin kick in, preventing post-meal hypoglycemia.

Fiasp vs. NovoLog: Potential Side Effects 

Fiasp and NovoLog cause the same common side effects, which include: 

    • Hypoglycemia 
    • Allergic reactions
    • Hypersensitivity
    • Injection/Infusion site reactions
    • Lipodystrophy
    • Weight gain

Patients allergic to niacinamide may experience more discomfort from using Fiasp. Overall, the long-term safety profiles of both insulins are similar, with no significant differences in complications.

Serious health risks include: 

    • Hyperglycemia or excessively high blood sugar levels
    • Hypoglycemia or excessively low blood sugar levels
    • Hypersensitivity reactions
    • Hypokalemia or low potassium levels
    • Fluid retention and heart failure
    • Ketoacidosis

These severe adverse reactions are rare. However, if you experience symptoms related to these conditions, consult your doctor immediately. 

Fiasp vs. NovoLog Cost Comparison

Both Fiasp and NovoLog are manufactured by Novo Nordisk, so their price difference is often minimal. On average, Fiasp may be slightly more expensive. However, NovoLog is more commonly included in discount programs and rebates, resulting in a lower overall patient cost. Prices can also vary based on insurance coverage, pharmacy discounts, and location. Your insurance may favor NovoLog over Fiasp or vice versa, affecting your copay amounts. 

Buying your prescriptions from Canadian pharmacies can significantly reduce the cost. The table below compares the average price of Fiasp and NovoLog in the U.S. vs. Canada. 

Insulin Average Cost in the U.S. Buy Canadian Insulin Price
Fiasp Vial 100u/mL $348 $58
Fiasp FlexTouch Pen 100u/mL $674.80 $124
Fiasp Cartridges 100u/mL $645 $115
NovoLog Vial 100u/mL $400 $79
NovoLog Penfill Cartridges 100u/mL $864 $136

To manage insulin costs, consider buying Fiasp or NovoLog from reliable online prescription platforms like Buy Canadian Insulin, where you can save up to 90% on your medication. 

Are Fiasp and NovoLog Interchangeable?

Fiasp Insulin Pen Box

If you’re considering switching medications, let your doctor know. Fiasp and NovoLog are rapid-acting insulins and share the same base ingredient, insulin aspart, but the former contains L-arginine and niacinamide. This minor difference in formulation can impact how quickly it works and how your body responds.

In most cases, your doctor may approve a direct switch with a 1:1 dosing conversion if you’re already taking mealtime insulin. However, it’s not always a 1:1 substitution. Your doctor may adjust your dosage depending on your response. 

Since Fiasp works more quickly, they may suggest changing your mealtimes, or they may instruct you to monitor your blood glucose more frequently during the transition. 

Before switching, talk to your doctor to ensure Fiasp or NovoLog fits your current diabetes management plan. 

Alternatives and Equivalents: Exploring Other Options

The closest match for a Fiasp equivalent is NovoLog or NovoRapid — both are rapid-acting insulins that contain an identical base substance, insulin aspart.

Other Fiasp alternatives include: 

  • Humalog: Contains insulin lispro
  • Lyumjev: Contains insulin lispro

The key difference between Fiasp vs. Humalog for diabetes is the onset of action. Fiasp typically acts quicker, which may benefit patients requiring better post-meal control. 

If your option for diabetes is between Fiasp and Lyumjev, the latter may offer a slightly faster onset. If Fiasp contains niacinamide and L-arginine, Lyumjev uses treprostinil (a vasodilator) and sodium citrate dihydrate, which help accelerate insulin absorption even further. It’s one of the fastest insulins available today. 

Meanwhile, some options for NovoLog alternatives include: 

  • Merilog: Contains insulin-aspart-szjj. It’s the first ever rapid-acting insulin approved by the FDA in February 2025 as a biosimilar to NovoLog. 
  • Humalog: Contains insulin lispro and is also a rapid-acting insulin
  • Apidra: Contains insulin glulisine and is also a rapid-acting insulin

You might consider switching due to insurance changes, side effects, or personal preference. Always speak with your doctor to choose the best insulin for your needs.

Fiasp vs. NovoLog: Which Insulin is Right for You?

Both Fiasp and NovoLog are rapid-acting insulins that help patients with diabetes manage their condition and prevent complications. Between the two, Fiasp has a faster onset of action due to added ingredients like niacinamide. It’s a good option if you need tighter post-meal blood sugar control.

NovoLog, on the other hand, works slightly slower, but it’s not in any way less effective than Fiasp for managing blood glucose. It’s a reliable option for patients with structured meal schedules and works well with most diabetes plans. 

Choosing between Fiasp vs. NovoLog depends on your daily routine, your tolerance to side effects, and how quickly you need to regulate your blood sugar levels. Work with your doctor to determine which insulin best fits your health goals and needs. 

Frequently Asked Questions

Fiasp works faster than NovoLog because niacinamide and L-arginine have been added to its formulation to accelerate absorption. Some people may find it better at controlling or preventing post-meal spikes.
Some disadvantages or side effects associated with Fiasp are severe low blood sugar, allergic reactions, injection site reactions, weight gain, and lipodystrophy. These common symptoms are often temporary, but consult your doctor if they persist.
Your doctor may approve a 1:1 dosing conversion if you already use mealtime insulin. NovoLog is the most closely related insulin to Fiasp, as both contain insulin aspart. Other rapid-acting alternatives are Humalog and Lyumjev, but they have different active ingredients.
The glucose-lowering effect of Fiasp starts working in only about 2.5 minutes. This faster onset gives users more flexibility to take the shot before or after a meal. It may work better than standard rapid-acting insulins at preventing post-meal spikes.
Your doctor may recommend Fiasp if NovoLog isn’t working for you or doesn’t fit well into your diabetes plan. For instance, they may switch you to Fiasp if you need insulin that takes effect fast. Always consult your doctor before making any medication changes to minimize risks.

Original Publish Date: 5/17/2021 – Updated 6/2/2025